Home Medicine Diabetes does not affect motor recovery after intracerebral hemorrhage
Article Open Access

Diabetes does not affect motor recovery after intracerebral hemorrhage

  • Seung Hwa Jang , Sang Gyu Kwak and Min Cheol Chang EMAIL logo
Published/Copyright: August 25, 2020
Download Article (PDF)
Translational Neuroscience
From the journal Translational Neuroscience Volume 11 Issue 1

Abstract

Background

This retrospective study evaluated whether diabetes affects motor outcome after stroke by analyzing the effects of diabetes on motor prognosis by controlling for critical factors, including lesion type and location, corticospinal tract (CST) state, patient age, lesion volume, and treatment method during the stroke.

Methodology

We recruited 221 patients with intracerebral hemorrhage (ICH) of the basal ganglia. We used diffusion tensor tractography to investigate the CST state. We also evaluated the hemorrhage volume. We obtained information on the presence of diabetes and age by chart review. Motor outcomes at 6 months were measured using the upper and lower limb motricity index (MI), modified Brunnstrom classification (MBC), and functional ambulation category (FAC). We used multiple linear regression tests to investigate whether diabetes affected motor outcomes after stroke after adjusting for other factors, including CST state, age, lesion volume, and treatment method.

Results

The presence of diabetes was not correlated with motor outcome measurements, including upper and lower MIs, MBC, and FAC, at 6 months after the onset. However, the CST state, age, lesion volume, and treatment method were significantly correlated with nearly all motor outcomes.

Conclusions

We found that diabetes did not significantly affect motor outcomes after ICH.

Keywords: diabetes; motor outcome; diffusion tensor tractography; intracerebral hemorrhage

1 Introduction

Motor deficits are a major sequela after stroke [1,2,3], hindering patient’s independent activities of daily living and deteriorating the quality of life [3]. After stroke, more than half of the patients have significant motor deficits. Several factors including the state of motor-related neural tracts, lesion location, patient age, and treatment method reportedly affect motor outcomes after stroke [2,4,5,6,7]. While previous studies have evaluated the effects of diabetes on motor recovery after stroke [8,9,10], this topic remains controversial. Most of these studies did not control for factors that can affect the motor recovery of stroke patients [7,8,9,10], which may have contributed to the unreliable conclusions.

The current study aimed to accurately evaluate the effects of diabetes on motor recovery after stroke by recruiting only patients with intracerebral hemorrhage (ICH) in the basal ganglia (BG). Furthermore, we controlled for critical factors, including the state of the corticospinal tract (CST), age, lesion volume, and treatment method. We also evaluated the CST state using recently developed diffusion tensor tractography (DTT) derived from diffusion tensor imaging (DTI).

2 Materials and methods

2.1 Subjects

This retrospective study recruited 221 patients admitted for rehabilitation at the Department of Rehabilitation in a university hospital according to the following criteria (Table 1): (1) first-ever stroke, (2) age 20–80 years, (3) severe weakness of the affected extremities to the degree of being unable to move the affected limb without gravity and complete weakness of the affected hand (finger flexor and extensor) and ankle (ankle dorsiflexor and plantar flexor) within 24 h of onset, (4) a hematoma involving the BG seen on brain computed tomography (CT) with confirmation by a neuroradiologist (with the hematoma epicenter within the BG), (5) DTI scanning > 7 days after onset, and (6) the absence of serious medical complications such as cardiac problems or pneumonia, from onset to final evaluation. Patients with apraxia or severe cognitive problems were excluded.

Table 1

Demographic data and 6 month motor outcomes of the included patients

Age, years 53.8 ± 12.2
Sex (M:F), n 133:88
Lesion side (R:L), n 117:104
Hemorrhage volume, mL 29.9 ± 23.2
Surgery:conservative treatment, n 111:110
Diabetes:nondiabetes, n 44:177
From onset to DTT evaluation, day 47.6 ± 80.7
Preserved CST:interrupted CST 91:130
Initial MBC 1.0 ± 0.0
Initial FAC 0.0 ± 0.0
UMI (6 months after onset) 52.4 ± 26.4
LMI (6 months after onset) 59.4 ± 23.5
MBC (6 months after onset) 3.6 ± 2.0
FAC (6 months after onset) 3.0 ± 1.5

Abbreviations: DTT, diffusion tensor tractography; CST, corticospinal tract; MBC, modified Brunnstrom classification; FAC, functional ambulation category; MI, motricity Index.

Values are presented as mean ± standard deviation.

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The study protocol was approved by the Institutional Research Board of the university hospital. The research related to human use has been complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration.

2.2 Clinical evaluation

Motor function was measured twice in each patient: at ICH onset and at 6 months after ICH onset. Motricity indices (MIs) were used to measure motor function (maximum score: 100) [11]. The functions of the affected hands were categorized using the modified Brunnstrom classification (MBC) (score range: 1–6) [12,13]. Walking ability was quantified using the standardized functional ambulation category (FAC) score (range: 0–5), which is based on characterizations of the levels of assistance required during a 15 m walk [14]. Higher MI, MBC, and FAC scores indicated better motor function.

2.3 DTI acquisition and CT analysis

DTI was performed using a sensitivity-encoding head coil on a 1.5-T Philips Gyroscan Intera (Hoffman-LaRoche, Ltd, Best, the Netherlands) with single-shot echo-planar imaging and navigator echo. Sixty contiguous slices (matrix = 128 × 128, field of view = 221 × 221 mm2, TE = 76 mm, TR = 10,726 ms, SENSE factor = 2; EPI factor = 67 and b = 1,000 s/mm/mm, number of excitations = 1, with a 2.3 mm slice thickness) were acquired for each of the 32 noncollinear diffusion-sensitizing gradients. The scanning time for DTI acquisition was 7 min 32 s. Head motion effects and image distortions due to eddy currents were corrected by multiscale affine two-dimensional (2D) registration.

Fiber connectivity was evaluated using fiber assignment by continuous tracking, a three-dimensional fiber reconstruction algorithm within the Philips PRIDE software (Philips Medical Systems, Best, the Netherlands). CST fiber tracking was performed using a fractional anisotropy (FA) threshold of >0.2 and a direction threshold of 60° [7]. In each case, a seed region of interest (ROI) was drawn in the CST portion of the anterior mid-pons on a two-dimensional (2D) FA color map; another ROI was also drawn in the CST portion of the anterior low-pons on a 2D FA color map. Fiber tracts passing through both ROIs were designated as the final tracts of interest (Figure 1). According to the CST integrity, the DTT findings were divided into either CST + (91 patients), in which the CST was preserved around the BG hematoma, that is, the CST originated from the cortex of the affected hemisphere and passed around the hematoma to the medulla, or to CST− (130 patients), in which the CST was interrupted at, or around, the hematoma.

Figure 1 DTT findings of the CST. (a) A 51 year-old woman with CST preservation around the hematoma on the BG. The CST originated from the cortex of the affected hemisphere and passed around the hematoma to the medulla. (b) A 52 year-old woman with interrupted CST at the hematoma on the BG. The tract does not reach the cortex of the affected hemisphere.
Figure 1

DTT findings of the CST. (a) A 51 year-old woman with CST preservation around the hematoma on the BG. The CST originated from the cortex of the affected hemisphere and passed around the hematoma to the medulla. (b) A 52 year-old woman with interrupted CST at the hematoma on the BG. The tract does not reach the cortex of the affected hemisphere.

2.4 Evaluation of the presence of diabetes

The patients were divided into two groups according to the presence of diabetes: DM+ (44 patients) and DM− (177 patients). The criteria for classifying patients into the DM+ group were fasting plasma glucose level ≥126 mg/dL, plasma glucose at 2 h after 75 g oral glucose load ≥200 mg/dL, HbA1c ≥ 6.5%, random plasma glucose ≥200 mg/dL with classic hyperglycemic symptoms, and previous diagnosis of type 2 diabetes [15]. Patients with type 1 diabetes were excluded from this study.

2.5 Estimation of hematoma volume

Hematoma volumes were calculated using initial CT scans. The largest diameters of the hematomas (A), the largest diameters of the hematoma perpendicular to A (B), and heights of hemorrhages were measured in centimeters (C). The formula used to estimate hematoma volume (mL) was as follows: hematoma volume = 4π/3 × (A/2) × (B/2) × (C/2) [16].

2.6 Statistical analysis

Data were analyzed using the IBM SPSS Statistics for Windows, version 23.0 (IBM Corp., Armonk, NY, USA). We performed multiple linear regression analysis to investigate whether diabetes affected motor outcomes after stroke. We presented the values of the regression coefficient, t-value, and p-value for each independent variable and determined the coefficient, F-value, and p-value for each regression model. The independent variables were the presence of diabetes, CST state, lesion volume, age, and treatment administered during ICH emergence (surgery or conservative treatment). The categorical variables (presence of diabetes and CST state) were converted into binary variables. For diabetes, the values were 1 and 0 if diabetes was present and absent, respectively. Regarding CST, the value was 1 if the CST was preserved and 0 if it was interrupted. Among treatment methods, the value was 1 if a surgery was performed and 0 if conservative treatment was used. In addition, we evaluated the correlation between the glycated hemoglobin (HbA1c) level and motor outcomes at 6 months after ICH onset using Pearson’s correlation tests. Statistical significance was defined as p values <0.05.

3 Results

The demographic data of the included patients are listed in Table 1 and Table S1. The average HbA1c value in patients with diabetes was 7.4% ± 1.6. The results of multiple linear regression analyses are listed in Table 2. The presence of diabetes was not correlated with motor outcome measurements, including upper MI (UMI) and lower MI (LMI), MBC, and FAC, at 6 months after onset (p > 0.05). However, the CST state, age, and lesion volume were significantly correlated with all motor outcomes (p < 0.05). The applied treatment method was correlated with UMI and LMIs and MBC (p < 0.05). CST preservation, younger age, smaller lesion volume, and surgery were predictive factors for good motor prognosis.

Table 2

Results of multiple regression analysis for UMI, LMI, MBC, and FAC

Dependent variable UMI LMI
Independent variable β t p-value β t p-value
CST state (preserved) 0.613 12.839 <0.001* 0.496 9.222 <0.001*
Diabetes (presence) −0.21 −0.455 0.649 −0.13 −0.775 0.799
Age −0.215 −4.518 <0.001* −0.245 −4.564 <0.001*
Hemorrhage volume −0.162 −3.065 0.002* −0.190 −3.198 0.002*
Treatment (surgery) 0.154 2.855 0.005* 0.159 2.618 0.009*
R 2, F (p-value) 0.565, 55.869 (<0.001*) 0.449, 35.006 (<0.001*)
Dependent variable MBC FAC
Independent variable β t p-value β t p-value
CST state (preserved) 0.649 14.394 <0.001* 0.367 6.310 <0.001*
Diabetes (presence) −0.008 −0.188 0.851 −0.011 −0.192 0.981
Age −0.172 −3.816 <0.001* −0.314 −5.411 <0.001*
Hemorrhage volume −0.161 −3.222 0.001* −0.237 −3.689 <0.001*
Treatment (surgery) 0.163 3.181 0.002* 0.126 1.915 0.057
R 2, F (p-value) 0.612, 67.861 (<0.001*) 0.345, 28.437 (<0.001*)

Abbreviations: CST, corticospinal tract; MI, motricity indices; MBC, modified Brunnstrom classification; FAC, functional ambulation category.

  1. *

    Statistically significant: p < 0.05.

In addition, there was no correlation between HbA1c level and motor outcome at 6 months after ICH onset (UMI: r = −0.096, p = 0.547; LMI: r = −0.169, p = 0.286; MBC: r = −0.088, p = 0.580; FAC: r = −0.190, p = 0.228).

4 Discussion

The current study evaluated the influence of diabetes on motor recovery in patients with ICH in the BG, adjusting for the CST integrity, age, hematoma volume, and treatment method.

Stroke type, lesion location and volume, and treatment method are important factors for motor prognosis in stroke patients [2,5,6,7]. The older the patient, the worse the prognosis [4]. Furthermore, CST integrity is a decisive factor in motor recovery [2,5,7]. Several DTT studies examining the CST in stroke patients showed that CST preservation is critical for motor recovery [2,7,17,18]. Therefore, using multiple linear regression analysis, we adjusted for these critical factors to accurately investigate the effects of diabetes on motor recovery after stroke. In our study, the CST state, age, lesion volume, and treatment method were significantly correlated with 6 month motor outcomes, a finding consistent with those of several previous studies. In 2002, Bagg et al. [19] prospectively evaluated the contribution of age to motor recovery in 640 patients, reporting that age was a significant predictor of functional independence at discharge after stroke treatment. Additionally, in 2008, Denti et al. [20] reported lower functional independent measurement scores upon discharge in stroke patients aged ≥75 years [21,22]. Moreover, the hematoma volume was significantly correlated with motor impairment after stroke. Large hematomas have a higher potential to damage brain areas that can contribute to motor recovery and motor-related neural tracts. Most ICHs do not require surgical treatment. However, early surgical removal of an intraparenchymal hematoma might be beneficial to reduce the mass effect, prevent or avoid midline shift, improve cerebral perfusion, and reduce the cascade of secondary brain injury [23]. Although the patients in our study who underwent surgery showed better motor outcomes than those who received conservative treatment, further studies are necessary.

In this study, diabetes did not affect 6 month motor outcomes, consistent with the results of some previous studies [8,9]. In 1995, Jørgensen et al. [8] evaluated the effect of diabetes on motor outcomes after stroke by comparing these outcomes at discharge following initial treatment for acute stroke in 176 and 902 patients with and without diabetes, respectively. They observed no significant differences in motor outcomes between these patient groups. In 2009, Nannetti et al. [9] measured the motor function of 93 stroke patients with diabetes and 302 stroke patients without diabetes after an average of 84.2 post-stroke days. They found that the scores (Barthel Index and Fugl–Meyer assessment scale) at the follow-up evaluations did not differ significantly between groups. In contrast to the results of our study, in 1983, Pulsinelli et al. [10] reported worse motor prognosis at discharge after cerebral infarct in 35 patients with diabetes compared with that in 72 patients without diabetes. Recently, in 2019, Moon et al. [7] analyzed the CST state using DTT in patients with corona radiata infarct. The patients were grouped based on the CST state and the presence of diabetes. They found that when the CST was interrupted, the presence of diabetes was a decisive factor in the patient’s motor recovery. However, the authors did not consider the influence of lesion volume or age. Lesion volume is a critical factor that can affect motor outcome after stroke; thus, their study is limited as they did not consider factors that should have been adjusted for. Other than Moon’s study, the other studies mentioned above did not consider the CST state, lesion location, age, lesion volume, or treatment method.

Although diabetes may inhibit motor recovery mechanisms such as perilesional reorganization and contributions from the secondary motor area, our results showed that diabetes did not significantly hinder motor recovery in stroke patients.

In conclusion, we found that diabetes did not significantly affect motor outcomes after ICH. Our study is the first to evaluate the effect of diabetes on motor recovery after stroke that controlled for multiple critical factors including the state of motor-related neural tracts, lesion location, age, lesion volume, and treatment method. However, our study is limited in that it was conducted retrospectively. Well-controlled prospective studies are warranted to clarify the effect of diabetes on motor recovery after stroke.

tel: +82-53-620-4682

  1. Conflict of interest: The authors state no conflict of interest.

  2. Funding: The present study was supported by a National Research Foundation of Korea grant funded by the Korean government (grant number NRF-2019R1F1A1061348).

References

[1] Jang SH, Chang MC. Motor outcomes of patients with a complete middle cerebral artery territory infarct. Neural Regen Res. 2013;8(20):1892–7.Search in Google Scholar

[2] Jang SH, Choi BY, Chang CH, Kim SH, Chang MC. Prediction of motor outcome based on diffusion tensor tractography findings in thalamic hemorrhage. Int J Neurosci. 2013;123(4):233–9.10.3109/00207454.2012.752364Search in Google Scholar PubMed

[3] Patel AT, Duncan PW, Lai SM. The relation between impairments and functional outcomes poststroke. Arch Phys Med Rehabil. 2000;81(10):1357–63.10.1053/apmr.2000.9397Search in Google Scholar PubMed

[4] Alawieh A, Zhao J, Feng W. Factors affecting post-stroke motor recovery: implications on neurotherapy after brain injury. Behav Brain Res. 2018;340:94–101.10.1016/j.bbr.2016.08.029Search in Google Scholar PubMed PubMed Central

[5] Chang MC, Do KH, Chun MH. Prediction of lower limb motor outcomes based on transcranial magnetic stimulation findings in patients with an infarct of the anterior cerebral artery. Somatosens Mot Res. 2015;32(4):249–53.10.3109/08990220.2015.1091769Search in Google Scholar PubMed

[6] Cheng B, Forkert ND, Zavaglia M, Hilgetag CC, Golsari A, Siemonsen S, et al. Influence of stroke infarct location on functional outcome measured by the modified rankin scale. Stroke. 2014;45(6):1695–702.10.1161/STROKEAHA.114.005152Search in Google Scholar PubMed

[7] Moon JS, Chung SM, Jang SH, Won KC, Chang MC. Effects of diabetes on motor recovery after cerebral infarct: a diffusion tensor imaging study. J Clin Endocrinol Metab. 2019;104:3851–8.10.1210/jc.2018-02502Search in Google Scholar PubMed

[8] Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The copenhagen stroke study. Stroke. 1994;25(10):1977–84.10.1161/01.STR.25.10.1977Search in Google Scholar PubMed

[9] Nannetti L, Paci M, Baccini M, Rinaldi LA, Taiti PG. Recovery from stroke in patients with diabetes mellitus. J Diabetes Complicat. 2009;23(4):249–54.10.1016/j.jdiacomp.2008.02.008Search in Google Scholar PubMed

[10] Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med. 1983;74(4):540–4.10.1016/0002-9343(83)91007-0Search in Google Scholar PubMed

[11] Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol. 1980;19(6):382–9.10.1159/000115178Search in Google Scholar PubMed

[12] Brunnstrom S. Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther. 1996;46(4):357–75.10.1093/ptj/46.4.357Search in Google Scholar PubMed

[13] Fujii Y, Nakada T. Cortical reorganization in patients with subcortical hemiparesis: neural mechanisms of functional recovery and prognostic implication. J Neurosurg. 2003;98(1):64–73.10.3171/jns.2003.98.1.0064Search in Google Scholar PubMed

[14] Cunha IT, Lim PA, Henson H, Monga T, Qureshy H, Protas EJ. Performance-based gait tests for acute stroke patients. Am J Phys Med Rehabil. 2002;81(11):848–56.10.1097/00002060-200211000-00008Search in Google Scholar PubMed

[15] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–90.10.2337/dc14-S081Search in Google Scholar PubMed

[16] Kothari RU, Brott TG, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304–5.10.1161/01.STR.27.8.1304Search in Google Scholar PubMed

[17] Cho SH, Kim DG, Kim DS, Kim YH, Lee CH, Jang SH. Motor outcome according to the integrity of the corticospinal tract determined by diffusion tensor tractography in the early stage of corona radiata infarct. Neurosci Lett. 2007;426(2):123–7.10.1016/j.neulet.2007.08.049Search in Google Scholar PubMed

[18] Jang SH, Bai D, Son SM, Lee J, Kim DS, Sakong J, et al. Motor outcome prediction using diffusion tensor tractography in pontine infarct. Ann Neurol. 2008;64(4):460–5.10.1002/ana.21444Search in Google Scholar PubMed

[19] Bagg S, Pombo AP, Hopman W. Effect of age on functional outcomes after stroke rehabilitation. Stroke. 2002;33(1):179–85.10.1161/hs0102.101224Search in Google Scholar PubMed

[20] Denti L, Agosti M, Franceschini M. Outcome predictors of rehabilitation for first stroke in the elderly. Eur J Phys Rehabil Med. 2008;44(1):3–11.Search in Google Scholar

[21] Ohnishi H, Takeda K, Watanabe M, Maeshima S, Sonoda S. Relationship between hematoma volume and motor impairment in putaminal hemorrhage. J Stroke Cerebrovasc Dis. 2020;29(6):104812.10.1016/j.jstrokecerebrovasdis.2020.104812Search in Google Scholar PubMed

[22] Yoo JS, Choi BY, Chang CH, Jung YJ, Kim SH, Jang SH. Characteristics of injury of the corticospinal tract and corticoreticular pathway in hemiparetic patients with putaminal hemorrhage. BMC Neurol. 2014;14:121.10.1186/1471-2377-14-121Search in Google Scholar PubMed PubMed Central

[23] de Oliveira Manoel AL. Surgery for spontaneous intracerebral hemorrhage. Crit Care. 2020;24:45.10.1186/s13054-020-2749-2Search in Google Scholar PubMed PubMed Central

Received: 2020-05-14
Revised: 2020-07-20
Accepted: 2020-08-04
Published Online: 2020-08-25

© 2020 Seung Hwa Jang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Changing the tone of clinical study design in the cannabis industry
  3. Integrated Chinese and western medicine for acute guillain-barré syndrome treatment
  4. Hydrochloride fasudil attenuates brain injury in ICH rats
  5. Protective role of maize purple plant pigment against oxidativestress in fluorosis rat brain
  6. A novel low-cost electrode for recording the local field potential of freely moving rat’s brain
  7. Neuroprotective mechanisms of erythropoietin in a rat stroke model
  8. Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
  9. Dysbiosis characteristics of gut microbiota in cerebral infarction patients
  10. miR-142-3p suppresses apoptosis in spinal cord-injured rats
  11. Decreased MiR-30a promotes TGF-β1-mediated arachnoid fibrosis in post-hemorrhagic hydrocephalus
  12. Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
  13. EGCG modulates PKD1 and ferroptosis to promote recovery in ST rats
  14. Efficacy of Novavit in ameliorating the neurotoxicity of propionic acid
  15. High-fat diet-induced obesity and impairment of brain neurotransmitter pool
  16. Erratum to “Changing the tone of clinical study design in the cannabis industry”
  17. Development of a trunk motor paradigm for use in neuroimaging
  18. Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity
  19. Saikosaponin A attenuates neural injury caused by ischemia/reperfusion
  20. Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice
  21. Partial enzyme digestion facilitates regeneration of crushed nerve in rat
  22. Correlation between calcium, water contents and ultrasonographic appearance of atherosclerotic lesions of carotid artery lesions
  23. Diabetes does not affect motor recovery after intracerebral hemorrhage
  24. IRF8 is crucial for the nicotine withdrawal-induced hyperalgesia in mice
  25. Prediction of muscle loss after stroke by analysis of corticospinal tract
  26. Interleukin-27 levels in patients with myasthenia gravis
  27. Artesunate attenuates traumatic brain injury-induced impairments in rats
  28. BDMC protects AD in vitro via AMPK and SIRT1
  29. Injury of the optic radiation in patients with mild TBI: A DTT study
  30. Time-restricted feeding alters isoflurane-induced memory deficits
  31. Video-based education improves the image quality of diagnostic percutaneous cerebral angiography among elderly patients
  32. The effect of rTMS in the management of pain associated with CRPS
  33. EGCG treats ICH via up-regulating miR-137-3p and inhibiting Parthanatos
  34. Modified hemispherectomy for infantile hemiparesis and epilepsy
  35. Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
  36. Epitranscriptome of the ventral tegmental area in a deep brain-stimulated chronic unpredictable mild stress mouse model
  37. Role of prefrontal cortex during Sudoku task: fNIRS study
  38. Tongxinluo promotes axonal plasticity and functional recovery after stroke
  39. Eriodictyol corrects functional recovery and myelin loss in SCI rats
  40. Letter to the Editor
  41. Ataxic hemiparesis after corona radiata infarct: Diffusion tensor imaging correlation of corticoponto-cerebellar tract injury
  42. Compression of the lateral antebrachial cutaneous nerve by a traumatic arteriovenous fistula
  43. Rapid Communication
  44. Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study
  45. Deviant cortical sulcation related to schizophrenia and cognitive deficits in the second trimester
  46. Case Report
  47. A case of primary central nervous system lymphoma mimic neuromyelitis optica
  48. A Moving Residual Limb: Botulinum Toxin to the Rescue
  49. Clinical and imaging features of reversible splenial lesion syndrome with language disorder
  50. Impaired consciousness due to injury of the ascending reticular activating system in a patient with bilateral pontine infarction: A case report
  51. Commentary
  52. A comment on Morey et al. (2020)
  53. Review Articles
  54. Advances in transcription factors related to neuroglial cell reprogramming
  55. The “authentic subjective experience” of memory in Alzheimer’s disease
  56. Chronic neurological diseases and COVID-19: Associations and considerations
  57. Special Issue "Neuroinflammation: from basic to clinical perspectives"
  58. Ormosanine improves neuronal functions in spinal cord-injured rats by blocking peroxynitrite/calpain activity
  59. Retraction
  60. Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
https://doi.org/10.1515/tnsci-2020-0125
Keywords for this article
diabetes; motor outcome; diffusion tensor tractography; intracerebral hemorrhage
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. Changing the tone of clinical study design in the cannabis industry
  3. Integrated Chinese and western medicine for acute guillain-barré syndrome treatment
  4. Hydrochloride fasudil attenuates brain injury in ICH rats
  5. Protective role of maize purple plant pigment against oxidativestress in fluorosis rat brain
  6. A novel low-cost electrode for recording the local field potential of freely moving rat’s brain
  7. Neuroprotective mechanisms of erythropoietin in a rat stroke model
  8. Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
  9. Dysbiosis characteristics of gut microbiota in cerebral infarction patients
  10. miR-142-3p suppresses apoptosis in spinal cord-injured rats
  11. Decreased MiR-30a promotes TGF-β1-mediated arachnoid fibrosis in post-hemorrhagic hydrocephalus
  12. Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer’s disease
  13. EGCG modulates PKD1 and ferroptosis to promote recovery in ST rats
  14. Efficacy of Novavit in ameliorating the neurotoxicity of propionic acid
  15. High-fat diet-induced obesity and impairment of brain neurotransmitter pool
  16. Erratum to “Changing the tone of clinical study design in the cannabis industry”
  17. Development of a trunk motor paradigm for use in neuroimaging
  18. Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity
  19. Saikosaponin A attenuates neural injury caused by ischemia/reperfusion
  20. Safety profile of the transcription factor EB (TFEB)-based gene therapy through intracranial injection in mice
  21. Partial enzyme digestion facilitates regeneration of crushed nerve in rat
  22. Correlation between calcium, water contents and ultrasonographic appearance of atherosclerotic lesions of carotid artery lesions
  23. Diabetes does not affect motor recovery after intracerebral hemorrhage
  24. IRF8 is crucial for the nicotine withdrawal-induced hyperalgesia in mice
  25. Prediction of muscle loss after stroke by analysis of corticospinal tract
  26. Interleukin-27 levels in patients with myasthenia gravis
  27. Artesunate attenuates traumatic brain injury-induced impairments in rats
  28. BDMC protects AD in vitro via AMPK and SIRT1
  29. Injury of the optic radiation in patients with mild TBI: A DTT study
  30. Time-restricted feeding alters isoflurane-induced memory deficits
  31. Video-based education improves the image quality of diagnostic percutaneous cerebral angiography among elderly patients
  32. The effect of rTMS in the management of pain associated with CRPS
  33. EGCG treats ICH via up-regulating miR-137-3p and inhibiting Parthanatos
  34. Modified hemispherectomy for infantile hemiparesis and epilepsy
  35. Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
  36. Epitranscriptome of the ventral tegmental area in a deep brain-stimulated chronic unpredictable mild stress mouse model
  37. Role of prefrontal cortex during Sudoku task: fNIRS study
  38. Tongxinluo promotes axonal plasticity and functional recovery after stroke
  39. Eriodictyol corrects functional recovery and myelin loss in SCI rats
  40. Letter to the Editor
  41. Ataxic hemiparesis after corona radiata infarct: Diffusion tensor imaging correlation of corticoponto-cerebellar tract injury
  42. Compression of the lateral antebrachial cutaneous nerve by a traumatic arteriovenous fistula
  43. Rapid Communication
  44. Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study
  45. Deviant cortical sulcation related to schizophrenia and cognitive deficits in the second trimester
  46. Case Report
  47. A case of primary central nervous system lymphoma mimic neuromyelitis optica
  48. A Moving Residual Limb: Botulinum Toxin to the Rescue
  49. Clinical and imaging features of reversible splenial lesion syndrome with language disorder
  50. Impaired consciousness due to injury of the ascending reticular activating system in a patient with bilateral pontine infarction: A case report
  51. Commentary
  52. A comment on Morey et al. (2020)
  53. Review Articles
  54. Advances in transcription factors related to neuroglial cell reprogramming
  55. The “authentic subjective experience” of memory in Alzheimer’s disease
  56. Chronic neurological diseases and COVID-19: Associations and considerations
  57. Special Issue "Neuroinflammation: from basic to clinical perspectives"
  58. Ormosanine improves neuronal functions in spinal cord-injured rats by blocking peroxynitrite/calpain activity
  59. Retraction
  60. Retraction of: Identification of biological markers for better characterization of older subjects with physical frailty and sarcopenia
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 16.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/tnsci-2020-0125/html
Scroll to top button